Analysts think GILD stock price could increase by 10%
Dec 04, 2025, 12:25 PM
-1.78%
What does GILD do
Gilead Sciences, headquartered in Foster City, California, employs 18,000 people and focuses on developing medicines for HIV, hepatitis, COVID-19, and cancer. Its portfolio includes numerous marketed products and several promising candidates.
30 analysts think GILD stock price will increase by 10.16%. The current median analyst target is $137.70 compared to a current stock price of $125.00. The lowest analysts target is $106.05 and the highest analyst target is $160.65.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.